Michael P. Malter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael P. Malter has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Rainer Surges
Department of Epileptology, University Hospital Bonn, Germany
4 shared publications - Christian G. Bien
Department of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center, Medical School OWL, Bielefeld University, Germany
3 shared publications C. Frisch
University of Bonn Medical Centre, Department of Epileptology, Germany
2 shared publicationsC. Helmstaedter
University of Bonn Medical Centre, Department of Epileptology, Germany
2 shared publicationsChristian E. Elger
2 shared publicationsH. Urbach
University Medical Centre Freiburg, Department of Neuroradiology, Germany
2 shared publications
Latest Publications
- 19 December 2017
- Published by Georg Thieme Verlag KG in Aktuelle Neurologie
- Vol. 45 (01) , 43
Erster epileptischer Anfall und Epilepsien im Erwachsenenalter
Bast T, Bauer J, Berkenfeld R et al. Erster epileptischer Anfall und Epilepsien im Erwachsenenalter Akt Neurol 2017; 44: 603–636 Aufgrund eines Versehens lautet die Überschrift zur neuropsychologischen Diagnostik in dem o. g. Beitrag auf Seite 613 in der rechten Spalte „Neurologische Diagnostik bei Epilepsiepatienten“ anstelle richtig „Neuropsychologische Diagnostik bei Epilepsiepatienten“.
- 19 December 2017
- Published by Georg Thieme Verlag KG in Aktuelle Neurologie
- Vol. 45 (01) , 43
Erster epileptischer Anfall und Epilepsien im Erwachsenenalter
Bast T, Bauer J, Berkenfeld R et al. Erster epileptischer Anfall und Epilepsien im Erwachsenenalter Akt Neurol 2017; 44: 603–636 Aufgrund eines Versehens lautet die Überschrift zur neuropsychologischen Diagnostik in dem o. g. Beitrag auf Seite 613 in der rechten Spalte „Neurologische Diagnostik bei Epilepsiepatienten“ anstelle richtig „Neuropsychologische Diagnostik bei Epilepsiepatienten“.
- 1 October 2015
- Published by Elsevier in Epilepsy Research
- Vol. 116, 8-14
Magnetic resonance imaging of focal cortical dysplasia: Comparison of 3D and 2D fluid attenuated inversion recovery sequences at 3T
- 1 October 2015
- Published by Elsevier in Epilepsy Research
- Vol. 116, 8-14
Magnetic resonance imaging of focal cortical dysplasia: Comparison of 3D and 2D fluid attenuated inversion recovery sequences at 3T
- 1 August 2015
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 30, 57-63
Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies
- 1 August 2015
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 30, 57-63
Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies
- 17 June 2014
- Published by Springer Nature in Journal of Neurology
- Vol. 261 (9) , 1695-1705
Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity
In limbic encephalitis (LE) with antibodies (Abs) to the voltage-gated potassium channel complex (VGKC), the Abs are mainly directed to the VGKC-complex proteins, leucine-rich, glioma inactivated 1 protein (LGI1) or contactin-associated protein-like 2 (CASPR-2) or neither. Here, we relate the outcomes of VGKC-LE patients to the presence of Abs to LGI1, CASPR-2 or neither antigen (LGI1/CASPR-2-Ab−). Clinical, neuropsychology and MRI data were obtained from patient records for all LE patients from the Bonn Epilepsy Centre positive for VGKC-Abs by radioimmunoprecipitation assay between 2002 and 2011. Eighteen VGKC-LE patients were identified: nine patients (50 %) had LGI1-Abs, three (16 %) had CASPR-2-Abs; and six (33 %) were negative for both LGI1- and CASPR-2-Abs. At first assessment, the groups did not differ clinically or radiologically, but faciobrachial dystonic seizures were only observed in two LGI1-Ab+ patients. All patients received monthly intravenous methylprednisolone (MP) pulses. At the most recent follow up (median 26 months), thirteen (72 %) were seizure-free, and seizure-freedom rates did not differ between the Ab groups. Hippocampal atrophy had developed in 7/9 LGI1-Ab+ patients, but in none of the CASPR-2-Ab+ or LGI/CASPR-2-Ab− patients (p = 0.003). While all subgroups improved, memory scores only normalized in six patients (33 %) and LGI1-Ab+ patients were left with significantly poorer memory than the other two subgroups. Most VGKC-LE patients become seizure-free with pulsed monthly MP, but memory outcome is less favourable. Hippocampal atrophy and poor memory recovery is common in patients with LGI1-Abs and suggests permanent functional damage. More intense immunotherapies could improve outcomes in LGI1-Ab+-LE.
- 17 June 2014
- Published by Springer Nature in Journal of Neurology
- Vol. 261 (9) , 1695-1705
Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity
In limbic encephalitis (LE) with antibodies (Abs) to the voltage-gated potassium channel complex (VGKC), the Abs are mainly directed to the VGKC-complex proteins, leucine-rich, glioma inactivated 1 protein (LGI1) or contactin-associated protein-like 2 (CASPR-2) or neither. Here, we relate the outcomes of VGKC-LE patients to the presence of Abs to LGI1, CASPR-2 or neither antigen (LGI1/CASPR-2-Ab−). Clinical, neuropsychology and MRI data were obtained from patient records for all LE patients from the Bonn Epilepsy Centre positive for VGKC-Abs by radioimmunoprecipitation assay between 2002 and 2011. Eighteen VGKC-LE patients were identified: nine patients (50 %) had LGI1-Abs, three (16 %) had CASPR-2-Abs; and six (33 %) were negative for both LGI1- and CASPR-2-Abs. At first assessment, the groups did not differ clinically or radiologically, but faciobrachial dystonic seizures were only observed in two LGI1-Ab+ patients. All patients received monthly intravenous methylprednisolone (MP) pulses. At the most recent follow up (median 26 months), thirteen (72 %) were seizure-free, and seizure-freedom rates did not differ between the Ab groups. Hippocampal atrophy had developed in 7/9 LGI1-Ab+ patients, but in none of the CASPR-2-Ab+ or LGI/CASPR-2-Ab− patients (p = 0.003). While all subgroups improved, memory scores only normalized in six patients (33 %) and LGI1-Ab+ patients were left with significantly poorer memory than the other two subgroups. Most VGKC-LE patients become seizure-free with pulsed monthly MP, but memory outcome is less favourable. Hippocampal atrophy and poor memory recovery is common in patients with LGI1-Abs and suggests permanent functional damage. More intense immunotherapies could improve outcomes in LGI1-Ab+-LE.
- 1 July 2013
- Published by Elsevier in Epilepsy Research
- Vol. 105 (1-2) , 150-157
Outcome after epilepsy surgery in patients with MRI features of bilateral ammon's horn sclerosis
- 1 July 2013
- Published by Elsevier in Epilepsy Research
- Vol. 105 (1-2) , 150-157
Outcome after epilepsy surgery in patients with MRI features of bilateral ammon's horn sclerosis
- Open Access
- 1 March 2013
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 22 (2) , 136-140
Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis
- 1 March 2013
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 22 (2) , 136-140
Open AccessDiagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis